The last 20 actions on file set price targets from $230.00 to $318.00, averaging $269.95.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 28 Sep 2026 | LifeSci Capital | BUY | $315.00 |
| 28 Sep 2026 | Brookline Capital | BUY | $318.00 |
| 24 Sep 2026 | Goldman Sachs | BUY | $267.00 |
| 21 Sep 2026 | BofA Securities | BUY | $265.00 |
| 16 Sep 2026 | RBC Capital | BUY | $251.00 |
| 14 Sep 2026 | LifeSci Capital | BUY | $315.00 |
| 13 Sep 2026 | Stifel | BUY | $230.00 |
| 10 Sep 2026 | Morgan Stanley | BUY | $255.00 |
| 9 Sep 2026 | Stifel | BUY | $230.00 |
| 3 Sep 2026 | Truist Financial | BUY | – |
| 3 Sep 2026 | Jefferies | BUY | $270.00 |
| 2 Sep 2026 | LifeSci Capital | BUY | $315.00 |
| 1 Sep 2026 | J.P. Morgan | BUY | $246.00 |
| 31 Aug 2026 | Needham | BUY | $275.00 |
| 29 Aug 2026 | LifeSci Capital | BUY | $315.00 |
| 28 Aug 2026 | UBS | BUY | $265.00 |
| 27 Aug 2026 | Wells Fargo | BUY | $240.00 |
| 27 Aug 2026 | Raymond James | BUY | $248.00 |
| 27 Aug 2026 | Truist Financial | BUY | $239.00 |
| 27 Aug 2026 | Jefferies | BUY | $270.00 |
No comments yet — be the first to weigh in on RVMD.